Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles.
暂无分享,去创建一个
A. Polo | O. Coll | D. Bodri | J. Guillén | C. Esteve | M. Trullenque
[1] S. Daneshmand,et al. Comparison of human chorionic gonadotropin and gonadotropin-releasing hormone agonist for final oocyte maturation in oocyte donor cycles. , 2007, Fertility and sterility.
[2] S. Coutre,et al. Von Willebrand disease presenting as recurrent hemorrhage after transvaginal oocyte retrieval. , 2007, American journal of obstetrics and gynecology.
[3] A. Abou-Setta,et al. Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review. , 2007, Reproductive biomedicine online.
[4] E. Ricciarelli,et al. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates. , 2006, Fertility and sterility.
[5] K. Diedrich,et al. Perioperative and post-operative complications of transvaginal ultrasound-guided oocyte retrieval: prospective study of >1000 oocyte retrievals. , 2006, Human reproduction.
[6] E. Kolibianakis,et al. Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. , 2006, Human reproduction update.
[7] E. Darai,et al. Uro-retroperitoneum after ultrasound-guided transvaginal follicle puncture in an oocyte donor: a case report. , 2006, Human reproduction.
[8] F. Figueras,et al. Comparison between a GnRH antagonist and a GnRH agonist flare-up protocol in oocyte donors: a randomized clinical trial. , 2006, Human reproduction.
[9] E. Kolibianakis,et al. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. , 2006, Human reproduction update.
[10] T. El-toukhy,et al. Pelvic infection after oocyte retrieval: A preventable complication or an inevitable risk? , 2006, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.
[11] M. Sauer,et al. Oocyte and embryo donation 2006: reviewing two decades of innovation and controversy. , 2006, Reproductive biomedicine online.
[12] A. Moini,et al. Endometriosis may contribute to oocyte retrieval-induced pelvic inflammatory disease: report of eight cases{1} , 2005, Journal of Assisted Reproduction and Genetics.
[13] S. Kol,et al. Recombinant gonadotrophin-based, ovarian hyperstimulation syndrome-free stimulation of the high responder: suggested protocol for further research. , 2005, Reproductive biomedicine online.
[14] J. Parsons,et al. Complications of transvaginal ultrasound-directed follicle aspiration: A review of 2670 consecutive procedures , 2005, Journal of Assisted Reproduction and Genetics.
[15] M. Laffan,et al. Thrombocythemia and hemoperitoneum after transvaginal oocyte retrieval for in vitro fertilization. , 2004, Fertility and sterility.
[16] G. Trew,et al. A review of complications following transvaginal oocyte retrieval for in-vitro fertilization , 2004, Human fertility.
[17] A. Volpe,et al. Short Communication: Severe Intraabdominal Bleeding After Transvaginal Oocyte Retrieval for IVF-ET and Coagulation Factor XI Deficiency: A Case Report , 2001, Journal of Assisted Reproduction and Genetics.
[18] S. Kol. Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. , 2004, Fertility and sterility.
[19] Serge Rozenberg,et al. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. , 2002, Human reproduction update.
[20] P. B. Miller,et al. Acute ureteral obstruction following transvaginal oocyte retrieval for IVF. , 2002, Human reproduction.
[21] G. Ambrosini,et al. Blood loss following noncomplicated transvaginal oocyte retrieval for in vitro fertilization. , 2001, Fertility and sterility.
[22] M. Sauer,et al. Defining the incidence of serious complications experienced by oocyte donors: a review of 1000 cases. , 2001, American journal of obstetrics and gynecology.
[23] J. Itskovitz‐Eldor,et al. Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: short communication. , 2000, Human reproduction.
[24] Y. Kluger,et al. Massive retroperitoneal bleeding: a complication of transvaginal ultrasonography-guided oocyte retrieval for in vitro fertilization-embryo transfer. , 2000, Fertility and sterility.
[25] Y. Englert,et al. Short-term medical complications of 1500 oocyte retrievals for in vitro fertilization and embryo transfer. , 1998, European journal of obstetrics, gynecology, and reproductive biology.
[26] A. Veiga,et al. Ureteral lesion secondary to vaginal ultrasound follicular puncture for oocyte recovery in in-vitro fertilization. , 1997, Human reproduction.
[27] A. Verhoeff,et al. The incidence of major clinical complications in a Dutch transport IVF programme. , 1996, Human reproduction update.
[28] W. Jiménez,et al. Treatment of severe ovarian hyperstimulation syndrome by a conservative medical approach , 1996, Acta obstetricia et gynecologica Scandinavica.
[29] R. Paulson,et al. Rare occurrence of ovarian hyperstimulation syndrome in oocyte donors , 1996, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[30] E. Katz,et al. Case Report: Perforated appendicitis and ectopic pregnancy following in-vitro fertilization , 1995 .
[31] J. Halme,et al. A case of severe ovarian hyperstimulation in a healthy oocyte donor. , 1995, Fertility and sterility.
[32] M. Sauer,et al. Endocrinology: Predictive value of serum oestradiol concentrations and oocyte number in severe ovarian hyperstimulation syndrome , 1995 .
[33] Z. Ben-Rafael,et al. Severe abdominal complications after transvaginal ultrasonographically guided retrieval of oocytes for in vitro fertilization and embryo transfer. , 1993, Fertility and sterility.
[34] L. Mastroianni,et al. Perioperative Complications Arising After Transvaginal Oocyte Retrieval , 1993, Obstetrics and gynecology.
[35] N. Laufer,et al. Ovarian hyperstimulation syndrome in novel reproductive technologies: Prevention and treatment , 1993 .
[36] A. Verhoeff,et al. Perforated appendicitis following transvaginal oocyte retrieval for in-vitro fertilization and embryo transfer. , 1992, Human reproduction.
[37] T. Bergh,et al. SHORT COMMUNICATION: Clinical complications during in-vitro fertilization treatment , 1992 .
[38] L. Enk,et al. Transvesical and Transvaginal Approaches for the Aspiration of Follicles by Use of Ultrasound , 1985, Annals of the New York Academy of Sciences.
[39] A. Trounson,et al. The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure , 1984, Nature.